VUL continues to execute as sustainable lithium demand surges. So what’s next?

Our investment Vulcan Energy Resources (ASX:VUL) has delivered everything it said they would do over the two years since we first invested. Heading into 2022, the company shows no signs of slowing down in achieving dual production of renewable energy and battery quality lithium chemicals with net zero carbon footprint.

Omicron, Inflation and Investment Memos

Many things can and do go wrong in small cap investing, so we found it was useful to note and understand what exactly went wrong with any of our companies that had a bad year, compared to what we thought should happen.

We Just Tripled Our Holding in TMR

We tripled our holdings in Tempus Resources (ASX: TMR) by participating in the placement last week at 14.5c.

WA Nickel Explorer ARN Just Identified 2 New Drill Targets

Nickel explorer Aldoro Resources (ASX: ARN) has confirmed two high confidence, ‘walk up’ drill targets. This means ARN is edging closer to its planned nickel drilling event.

This Stock Just IPO'd - Why we Invested

We recently took a large position in WA copper/gold explorer Techgen Metals (ASX: TG1) - in fact it is one of our biggest holdings.

Promising Results so Far… But there is Some More Work to Do…

Today 88 Energy (ASX: 88E) announced the interpretation of its ‘logging while drilling’ data. The progress results to date indicate multiple potentially hydrocarbon bearing zones have been encountered whilst drilling.

Amateur investor advice and … two stocks to watch

With the Deliveroo IPO on the horizon, a surge in the number of new investors jumping on the opportunity is a foregone conclusion, however it is essential for these investors to learn how the system works before engaging with it.

Tell Me Why: The 10 Reasons We Invested in ONE

Last Friday we announced our 2021 Tech Pick of the Year, Oneview Healthcare plc (ASX: ONE) - a healthcare technology company that enables ‘virtual care’ at the bedside for hospital patients. We promised that we would provide further analysis on why we have made such a large, long term investment and called ONE our 2021 Tech Pick of the Year…

Short Term Trade Update: What’s Happening to the CPH Share Price?

We put out a short note on Creso Pharma (ASX: CPH) to some of you that might have previously invested in the stock and not had a positive experience. After a couple of false starts, our plan is to ride this momentum over the coming weeks and hopefully recoup some of our previous losses.

What effect will the US election have on markets?

Analysis suggests there is no statistically significant correlation between the political party in office and equity market performance.

We are Rolling the Dice on this One…

Long term Creso Pharma (ASX: CPH) shareholders have had a rough ride in the last 12 months. Last week the $20M capped CPH raised circa A$9M at $0.0291 per share, finally extinguishing the company’s debt and ridding the company of major con note holders that were hampering any share price appreciation.

Investing in Australian tech stocks

The ASX is well regulated and lists some of the world’s best companies: so, while some world markets may outperform our market for short periods, over the long term it not only holds its weight but outperforms nearly all other world markets in terms of return.

Re-think your wealth strategy: pay off your home loan or invest?

Everyone should look at this low interest rate environment as a once in a lifetime opportunity to not only reduce housing debt but also invest for the future.

Is stock diversification really a good strategy?

Spend less time worrying about which sector to invest in and spend more time looking for good stocks, because smart investing is about buying what goes up and selling what goes down.

Don't overestimate your knowledge in the stock market

According to many surveys conducted by the ASX, it is common to find around 50 per cent of adult Australians believe they are very knowledgeable or somewhat knowledgeable when it comes to investing in shares. Are they overestimating their abilities?

Why dividends shouldn't dictate your investment strategy

It has been general practice for investors, especially retirees, to invest in high dividend paying stocks to generate income. While there is some merit with this strategy, the opposite may be the case.

Are you a sophisticated investor?
Find out more
Please note: Raisebook is a related entity of S3 Consortium Pty Ltd as defined in Section 9 of the Corporations Act 2001.